IDEAL_ANSWER:
- Small-molecule inhibition of METTL3 is a strategy against myeloid leukaemia. Targeting of RNA-modifying enzymes represents a promising avenue for anticancer therapy.
- Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.

EXACT_ANSWER:
- myeloid leukaemia